Correlation Between Changchun BCHT and China Satellite

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Changchun BCHT and China Satellite at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Changchun BCHT and China Satellite into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Changchun BCHT Biotechnology and China Satellite Communications, you can compare the effects of market volatilities on Changchun BCHT and China Satellite and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Changchun BCHT with a short position of China Satellite. Check out your portfolio center. Please also check ongoing floating volatility patterns of Changchun BCHT and China Satellite.

Diversification Opportunities for Changchun BCHT and China Satellite

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Changchun and China is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Changchun BCHT Biotechnology and China Satellite Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Satellite Comm and Changchun BCHT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Changchun BCHT Biotechnology are associated (or correlated) with China Satellite. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Satellite Comm has no effect on the direction of Changchun BCHT i.e., Changchun BCHT and China Satellite go up and down completely randomly.

Pair Corralation between Changchun BCHT and China Satellite

Assuming the 90 days trading horizon Changchun BCHT Biotechnology is expected to under-perform the China Satellite. But the stock apears to be less risky and, when comparing its historical volatility, Changchun BCHT Biotechnology is 1.06 times less risky than China Satellite. The stock trades about -0.08 of its potential returns per unit of risk. The China Satellite Communications is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,777  in China Satellite Communications on September 26, 2024 and sell it today you would earn a total of  369.00  from holding China Satellite Communications or generate 20.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Changchun BCHT Biotechnology  vs.  China Satellite Communications

 Performance 
       Timeline  
Changchun BCHT Biote 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Changchun BCHT Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Changchun BCHT sustained solid returns over the last few months and may actually be approaching a breakup point.
China Satellite Comm 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in China Satellite Communications are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Satellite sustained solid returns over the last few months and may actually be approaching a breakup point.

Changchun BCHT and China Satellite Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Changchun BCHT and China Satellite

The main advantage of trading using opposite Changchun BCHT and China Satellite positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Changchun BCHT position performs unexpectedly, China Satellite can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Satellite will offset losses from the drop in China Satellite's long position.
The idea behind Changchun BCHT Biotechnology and China Satellite Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance